Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals

Microbial Drug Resistance

Volumn 24, Issue 1, 2018, Pages 48-54

  Correa, Adriana ^a   Del Campo, Rosa ^b   Escandón Vargas, Kevin ^a   Perenguez, Marcela ^a   Rodríguez Banõs, Mercedes ^b   Hernández Gómez, Cristhian ^a   Pallares, Christian ^a   Perez, Federico ^c,d   Arias, Cesar A ^e,f   Cantón, Rafael ^b   Villegas, Mariá V ^a  

^a Bacterial Resistance and Hospital Epidemiology Unit   (Colombia)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f UNIVERSIDAD EL BOSQUE   (Colombia)

Author keywords

Acinetobacter baumannii; antibiotic resistance; carbapenemase; multilocus sequence typing; OXA enzymes

Indexed keywords

AMIKACIN; BETA LACTAMASE; BETA LACTAMASE OXA 23; BETA LACTAMASE OXA 24; BETA LACTAMASE OXA 51; BETA LACTAMASE OXA 58; CARBAPENEM; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CIPROFLOXACIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONE; COLOMBIA; GENE LOCUS; GENETIC VARIABILITY; HOSPITAL; HUMAN; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; ACINETOBACTER INFECTION; BETA-LACTAM RESISTANCE; CELL CLONE; CLASSIFICATION; CLINICAL TRIAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTICENTER STUDY; SEROTYPE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CLONE CELLS; COLOMBIA; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VARIATION; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; SEROGROUP;

EID: 85040543528     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2016.0190     Document Type: Article

References (36)

1. Runnegar, N., H. Sidjabat, H.M.S. Goh, G.R. Nimmo, M.A. Schembri, D.L. Paterson. 2010. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J. Clin. Microbiol. 48:4051-4056.
2. Turton, J.F., M.E. Ward, N. Woodford, M.E. Kaufmann, R. Pike, D.M. Livermore, T.L. Pitt. 2006. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258: 72-77.
3. Evans, B.A., S.G.B. Amyes. 2014. OXA b-lactamases. Clin. Microbiol. Rev. 27:241-263.
4. Bartual, S.G., H. Seifert, C. Hippler, M.A.D. Luzon, H. Wisplinghoff, F. Rodŕguez-Valera. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:4382-4390.
5. Diancourt, L., V. Passet, A. Nemec, L. Dijkshoorn, S. Brisse. 2010. The population structure of Acinetobacter baumannii: Expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5: E10034.
6. Tomaschek, F., P.G. Higgins, D. Stefanik, H. Wisplinghoff, H. Seifert. 2016. Head-to-head comparison of two multi-locus squence typing (MLST) schemes for characterization of Acinetobacter baumannii outbreak and sporadic isolates. PLoS One 11:e0153014.
7. Karah, N., A. Sundsfjord, K. Towner, ∅. Samuelsen. 2012. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist. Updat. 15:237-247.
8. Dai, W., S. Huang, S. Sun, J. Cao, L. Zhang. 2013. Nosocomial spread of carbapenem-resistant Acinetobacter baumannii (types ST75 and ST137) carrying blaOXA-23-like gene with an upstream ISAba1 in a Chinese hospital. Infect. Genet. Evol. 14:98-101.
9. Ruan, Z., Y. Chen, Y. Jiang, H. Zhou, Z. Zhou, Y. Fu, H. Wang, Y. Wang, Y. Yu. 2013. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int. J. Antimicrob. Agents 42:322-328.
10. Grosso, F., K.R. Carvalho, S. Quinteira, A. Ramos, A.P.D. Carvalho-Assef, M.D. Asensi, L. Peixe. 2011. OXA-23-producing Acinetobacter baumannii: A new hotspot of diversity in Rio de Janeiro J. Antimicrob. Chemother. 66: 62-65.
11. Martins, N., I.S. Martins, W.V. de Freitas, J.A. de Matos, V.B.D.C. Giraõ, T. Coelho-Souza, A.C.D.G. Maralhães, L.C. Cacci, M.P. de Figueiredo, R.C.S. Dias, A.P.R. Costa-Lourenço, A.L.P. Ferreira, L. Dalla-Costa, S.A. Nouér, G. Santoro-Lopes, L.W. Riley, B.M. Moreira. 2013. Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: One-year prospective cohort study in intensive care patients. Microb. Drug Resist. 19:216-223.
12. Cĺmaco, E.C., M.L. de Oliveira, A. Pitondo-Silva, M.G. Oliveira, M. Medeiros, N. Lincopan, A.L. da Costa Darini. 2013. Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXA-carbapenemaseproducing Acinetobacter baumannii in Southeast Brazil. Infect. Genet. Evol. 19:127-133.
13. Coelho-Souza, T., J.N. Reis, N. Martins, I.S. Martins, A.O. Menezes, M.G. Reis, N.O. Silva, R.C.S. Dias, L.W. Riley, B.M. Moreira. 2013. Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil. Clin. Microbiol. Infect. 19:E241-E244.
14. Martins, N., L. Dalla-Costa, A.A. Uehara, L.W. Riley, B.M. Moreira. 2013. Emergence of Acinetobacter baumannii international clone II in Brazil: Reflection of a global expansion. Infect. Genet. Evol. 20:378-380.
15. Chagas, T.P.G., K.R. Carvalho, I.C. de Oliveira Santos, A.P.D. Carvalho-Assef, M.D. Asensi. 2014. Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): Countrywide spread of OXA-23-producing clones (CC15 and CC79). Diagn. Microbiol. Infect. Dis. 79:468-472.
16. Vasconcelos, A.T.R., A.L. Barth, A.P. Zavascki, A.C. Gales, A.S. Levin, B.R. Lucarevschi, et al. 2015. The changing epidemiology of Acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: A BrasNet report. Diagn. Microbiol. Infect. Dis. 83:382-385.
17. Cardoso, J.P., R. Cayô, R. Girardello, A.C. Gales. 2016. Diversity of mechanisms conferring resistance to b-lactams among OXA-23-producing Acinetobacter baumannii clones. Diagn. Microbiol. Infect. Dis. 85:90-97.
18. Camargo, C.H., M.R. Tiba, M.R. Saes, F.M. de Vasconcellos, L.F. Dos Santos, E.C. Romero, D. de O. Garcia. 2016. Population structure analysis of carbapenem-resistant Acinetobacter baumannii clinical isolates from Brazil reveals predominance of clonal complexes 1, 15, 79. Antimicrob. Agents Chemother. 60:2545-2547.
19. Stietz, M.S., M.S. Raḿrez, E. Vilacoba, A.K. Merkier, A.S. Limansky, D. Centrón, M. Catalano. 2013. Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. Infect. Genet. Evol. 14:294-301.
20. Escandón-Vargas, K., S. Reyes, S. Gutiérrez, M.V. Villegas. 2017. The epidemiology of carbapenemases in Latin America and the Caribbean. Expert Rev. Anti. Infect. Ther. 15:277-297.
21. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th edition. CLSI document M100-S24. Wayne, PA.
22. Jones, R.N., M.J. Ferraro, L.B. Reller, P.C. Schreckenberger, J.M. Swenson, H.S. Sader. 2007. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J. Clin. Microbiol. 45:227-230.
23. Woodford, N., M.J. Ellington, J.M. Coelho, J.F. Turton, M.E. Ward, S. Brown, S.G.B. Amyes, D.M. Livermore. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353.
24. Gautom, R.K. 1997. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J. Clin. Microbiol. 35: 2977-2980.
25. Castanheira, M., S.E. Costello, L.N. Woosley, L.M. Deshpande, T.A. Davies, R.N. Jones. 2014. Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel b-lactamases, GES-22 and VIM-35. Antimicrob. Agents Chemother. 58:7358-7366.
26. Cortivo, G.D., A. Gutberlet, J.A. Ferreira, L.E. Ferreira, R.C. Deglmann, G.A. Westphal, P.H.C. de Franca. 2015. Antimicrobial resistance profiles and oxacillinase genes in carbapenem-resistant Acinetobacter baumannii isolated from hospitalized patients in Santa Catarina, Brazil. Rev. Soc. Bras. Med. Trop. 48:699-705.
27. Zowawi, H.M., A.L. Sartor, H.E. Sidjabat, H.H. Balkhy, T.R. Walsh, S.M. Al Johani, R.Y. AlJindan, M. Alfaresi, E. Ibrahim, A. Al-Jardani, J. Al Salman, A.A. Dashti, K. Johani, D.L. Paterson. 2015. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: Dominance of OXA-23-type producers. J. Clin. Microbiol. 53:896-903.
28. Mugnier, P.D., L. Poirel, T. Naas, P. Nordmann. 2010. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16:35-40.
29. Catel-Ferreira, M., G. Coadou, V. Molle, P. Mugnier, P. Nordmann, A. Siroy, T. Jouenne, E. Dé. 2011. Structurefunction relationships of CarO, the carbapenem resistanceassociated outer membrane protein of Acinetobacter baumannii. J. Antimicrob. Chemother. 66:2053-2056.
30. Fernández-Cuenca, F., L. Martnez-Martnez, M.C. Conejo, J.A. Ayala, E.J. Perea, A. Pascual. 2003. Relationship between b-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51:565-574.
31. Hamouda, A., B.A. Evans, K.J. Towner, S.G.B. Amyes. 2010. Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, sequence-based typing of blaOXA-51-like genes. J. Clin. Microbiol. 48:2476-2483.
32. Martnez, P., S. Mattar. 2012. Imipenem-resistant Acinetobacter baumannii carrying the ISAba1-blaOXA-23, 51 and ISAba1-blaADC-7 genes in Monteria, Colombia. Braz. J. Microbiol. 43:1274-1280.
33. Reguero, M.T., O.E. Medina, M.A. Hernández, D.V. Flórez, E.M. Valenzuela, J.R. Mantilla. 2013. Antibiotic resistance patterns of Acinetobacter calcoaceticus-A. baumannii complex species from Colombian hospitals. Enferm. Infect. Microbiol. Clin. 31:142-146.
34. Hernández-Gómez, C., V.M. Blanco, G. Motoa, A. Correa, J.J. Maya, E. de la Cadena, M. Perenguëz, L. Rojas, A. Hernández, M. Vallejo, M.V. Villegas, G. de R.B.N. en Colombia. 2014. Evolution of antimicrobial resistance in Gram negative bacilli from intensive care units in Colombia. Biomedica 34:91-100.
35. Vanegas, J.M., L.F. Higuita, C.A. Vargas, A.V. Cienfuegos, E .A. Rodŕguez, G.E. Roncancio, J.N. Jiménez. 2015. Carbapenem-resistant Acinetobacter baumannii causing osteomyelitis and infections of skin and soft tissues in hospitals of Medelĺn, Colombia. Biomedica 35:522-530.
36. Gonzalez-Villoria, A.M., E. Tamayo-Legorreta, U. Garza-Ramos, H. Barrios, A. Sanchez-Pérez, N. Rodŕguez-Medina, N. Uribe-Avinã, M.A. Cevallos, CRAB Study Group, J. Silva-Sanchez. 2016. A multicenter study in Mexico finds Acinetobacter baumannii clinical isolates belonging to clonal complexes 636B (113B) and 92B harboring OXA-72, OXA-239, OXA-469. Antimicrob. Agents Chemother. 60: 2587-2588.